Clinical Trial Update: Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update on PTP-001 (MOTYS) for symptomatic knee osteoarthritis with ongoing activity and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• PTP-001 (MOTYS™)

Snippet

Sponsor: Bioventus LLC | Conditions: Osteoarthritis, Knee | Phase 2 | Status: ACTIVE_NOT_RECRUITING